Date and time
Start: Thursday 1 May 2025, 12:30 PM
End: Thursday 1 May 2025, 01:30 PM
Thursday 1 May
Start: Thursday 1 May 2025, 12:30 PM
End: Thursday 1 May 2025, 01:30 PM
We will provide an overview of SPC updates in both the UK and at the CJEU. For the UK, this will include a discussion of new SPC decisions, as well as the new Windsor Framework set up. We’ll also touch on the most recent news and decisions from the CJEU.
All
David has a diverse practice, working with therapeutic proteins, modified nucleic acids and traditional small molecules. He has worked on SPCs for a wide range of products, including Jakavi, Spinraza and Evarrest. Clients often rely on David to manage oppositions and patent prosecution that interlink with the SPC strategy. As part of this work, he assesses both the SPC and patent coverage, and the interplay with the regulatory protection available to his clients. David is frequently involved in appeals against SPC refusals across Europe, including hearings at the UKIPO and supporting litigation in Spain and Sweden.
Hannah handles a wide variety of subject-matter at all stages of the product lifecycle, ranging from new chemical entities, crystal forms and medical uses to medical devices and consumer products. Hannah has worked on multiple SPC families related to small molecule drugs, including advising on SPC filing strategies and handling filing and prosecution before national patent offices.
The event has been added to your basket:
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here